Compare CAAP & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAAP | SHC |
|---|---|---|
| Founded | 1998 | 2015 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 5.0B |
| IPO Year | 2017 | 2020 |
| Metric | CAAP | SHC |
|---|---|---|
| Price | $23.70 | $18.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $26.73 | $20.33 |
| AVG Volume (30 Days) | 198.3K | ★ 1.8M |
| Earning Date | 05-21-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | N/A | ★ 0.28 |
| Revenue | N/A | ★ $1,163,617,000.00 |
| Revenue This Year | $5.80 | $7.51 |
| Revenue Next Year | $2.36 | $6.00 |
| P/E Ratio | ★ $26.35 | $67.68 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $17.36 | $13.09 |
| 52 Week High | $30.50 | $19.85 |
| Indicator | CAAP | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 44.09 | 50.94 |
| Support Level | $22.02 | $18.20 |
| Resistance Level | $26.73 | $19.79 |
| Average True Range (ATR) | 0.71 | 0.43 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 30.85 | 48.47 |
Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.